These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Amyopathic dermatomyositis or dermatomyositis-like skin disease: retrospective review of 16 cases with amyopathic dermatomyositis. Cao H; Parikh TN; Zheng J Clin Rheumatol; 2009 Aug; 28(8):979-84. PubMed ID: 19294477 [TBL] [Abstract][Full Text] [Related]
6. [Comparison of clinical and immunological features between clinically amyopathic dermatomyositis and typical dermatomyositis]. Gan YZ; Li YH; Zhang LH; Ma L; He WW; Jin YB; An Y; Li ZG; Ye H Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1001-1008. PubMed ID: 33331305 [TBL] [Abstract][Full Text] [Related]
7. Juvenile-onset clinically amyopathic dermatomyositis: an overview of recent progress in diagnosis and management. Walling HW; Gerami P; Sontheimer RD Paediatr Drugs; 2010; 12(1):23-34. PubMed ID: 20034339 [TBL] [Abstract][Full Text] [Related]
8. Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects. Sontheimer RD Dermatol Clin; 2002 Jul; 20(3):387-408. PubMed ID: 12170874 [TBL] [Abstract][Full Text] [Related]
9. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab). Milgrom H; Berger W; Nayak A; Gupta N; Pollard S; McAlary M; Taylor AF; Rohane P Pediatrics; 2001 Aug; 108(2):E36. PubMed ID: 11483846 [TBL] [Abstract][Full Text] [Related]
10. Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease - a case report. Kishi T; Tani Y; Okiyama N; Mizuochi K; Ichimura Y; Harigai M; Nagata S; Miyamae T Pediatr Rheumatol Online J; 2021 Mar; 19(1):34. PubMed ID: 33740993 [TBL] [Abstract][Full Text] [Related]
11. When a Painful Rash Keeps Recurring: A Case of Seronegative Amyopathic Dermatomyositis Without Neurological Sequelae. Harazeen A; Walter B; Li X; Patel C Cureus; 2023 Jul; 15(7):e42727. PubMed ID: 37654955 [TBL] [Abstract][Full Text] [Related]
12. [Acute urticaria associated to omalizumab treatment in a child with asthma]. Velarde-Domínguez T; Pantoja-Alcantar JM; Martínez-Sáenz NP Rev Alerg Mex; 2012; 59(4):209-13. PubMed ID: 24008031 [TBL] [Abstract][Full Text] [Related]
13. Anti-MDA5 Antibody-Positive Interstitial Pneumonia with Autoimmune Features Presenting as Amyopathic Hypodermatitic Dermatomyositis: A Case Report. Mihailescu ML; Edens C; Hoffman MD Case Rep Dermatol; 2021; 13(1):222-229. PubMed ID: 34054457 [TBL] [Abstract][Full Text] [Related]
14. Amyopathic and anti-TIF1 gamma-positive dermatomyositis: analysis of a monocentric cohort and proposal to update diagnostic criteria. Didona D; Juratli HA; Scarsella L; Keber U; Eming R; Hertl M Eur J Dermatol; 2020 Jun; 30(3):279-288. PubMed ID: 32666928 [TBL] [Abstract][Full Text] [Related]
15. Omalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluation. Norman G; Faria R; Paton F; Llewellyn A; Fox D; Palmer S; Clifton I; Paton J; Woolacott N; McKenna C Health Technol Assess; 2013 Nov; 17(52):1-342. PubMed ID: 24267198 [TBL] [Abstract][Full Text] [Related]
17. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine. Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138 [TBL] [Abstract][Full Text] [Related]
18. Omalizumab therapy in a 13-year-old boy with severe persistent asthma and concomitant eosinophilic esophagitis. Arasi S; Costa S; Magazzù G; Ieni A; Crisafulli G; Caminiti L; Chiera F; Vaccaro M; Del Giudice MM; Pajno GB Ital J Pediatr; 2016 Mar; 42():32. PubMed ID: 27000314 [TBL] [Abstract][Full Text] [Related]
19. Omalizumab as a Provoking Factor for Venous Thromboembolism. Oblitas CM; Galeano-Valle F; Vela-De La Cruz L; Del Toro-Cervera J; Demelo-Rodríguez P Drug Target Insights; 2019; 13():1177392819861987. PubMed ID: 31320796 [TBL] [Abstract][Full Text] [Related]
20. Treatment challenges in clinically amyopathic dermatomyositis: A case series and review of new therapeutic options for skin involvement. Rodríguez-Tejero A; López-Espadafor B; Montero-Vílchez T; Sánchez-Díaz M; Arias-Santiago S; Molina-Leyva A Dermatol Ther; 2021 May; 34(3):e14942. PubMed ID: 33719170 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]